TIIA at 0.34–3.4 μM induced leukemia NB4 and MR-2 cell differentiation as indicated by increased expression of CD11b, which was associated with up-regulation of C/EBPβ expression and increased C/EBPβ/CHOP ratio [173]. Here, DDIT3 is linked to leukemia.